Boston Trust Walden Corp lowered its position in STAG Industrial, Inc. (NYSE:STAG – Free Report) by 1.6% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 2,510,755 shares of the real estate investment…
Boston Trust Walden Corp boosted its stake in shares of Cincinnati Financial Co. (NASDAQ:CINF – Free Report) by 2.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned…
Boston Trust Walden Corp lessened its holdings in shares of Columbia Sportswear (NASDAQ:COLM – Free Report) by 1.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institution…
Boston Trust Walden Corp increased its stake in shares of Qualys, Inc. (NASDAQ:QLYS – Free Report) by 14.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned …
Boston Trust Walden Corp decreased its holdings in Hubbell Incorporated (NYSE:HUBB – Free Report) by 12.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 299,138 shares of the indu…
Boston Trust Walden Corp lowered its stake in Applied Industrial Technologies, Inc. (NYSE:AIT – Free Report) by 8.7% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 575,955 shares of the indust…
Boston Trust Walden Corp grew its position in shares of FactSet Research Systems Inc. (NYSE:FDS – Free Report) by 9.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The …
Boston Trust Walden Corp decreased its holdings in Chemed Co. (NYSE:CHE – Free Report) by 0.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 220,067 shares of…
Boston Trust Walden Corp trimmed its holdings in Waters Co. (NYSE:WAT – Free Report) by 12.3% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 471,919 shares…
Boston Trust Walden Corp raised its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 1.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned …
Boston Trust Walden Corp cut its stake in shares of Donaldson Company, Inc. (NYSE:DCI – Free Report) by 5.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2…
Boston Trust Walden Corp reduced its position in shares of AptarGroup, Inc. (NYSE:ATR – Free Report) by 1.3% in the third quarter, according to its most recent filing with the SEC. The fund owned 1,449,817 shares of the industrial products company’s s…
Boston Trust Walden Corp bought a new position in shares of Cullen/Frost Bankers, Inc. (NYSE:CFR – Free Report) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bo…
Boston Trust Walden Corp raised its stake in Essential Utilities, Inc. (NYSE:WTRG – Free Report) by 117.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,962,692 share…
Boston Trust Walden Corp decreased its position in AutoZone, Inc. (NYSE:AZO – Free Report) by 2.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 29,091 sh…
Dakota Wealth Management boosted its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 14.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 57,795 shares of…
SAM’s Q3 results reflect earnings growth, but challenges with Truly Seltzer and softer near-term category trends prompt a lower 2024 forecast.
Scotiabank boosted their price target on Boston Properties from $82.00 to $91.00 and gave the company a “sector outperform” rating in a research note on Friday.
Jefferies Financial Group lowered shares of Boston Beer from a “buy” rating to a “hold” rating and dropped their price objective for the company from $355.00 to $325.00 in a research note on Friday.
StockNews.com raised Boston Scientific from a “hold” rating to a “buy” rating in a research report on Thursday.
Boston Beer (SAM) delivered earnings and revenue surprises of 7.86% and 0.03%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Boston Beer (NYSE:SAM) updated its FY24 earnings guidance. The company provided EPS guidance of $8.00-$10.00 for the period, compared to the consensus estimate of $9.51.
UBS Group increased their price objective on Boston Beer from $300.00 to $309.00 in a research report on Thursday.
Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Boston Beer from $281.00 to $277.00 and set a “hold” rating on the stock in a research report on Thursday.
A Boston man had a strange encounter at a subway station. A month later, he discovered he was the star of the students’ viral video.
Axecap Investments LLC purchased a new position in Boston Scientific Co. (NYSE:BSX – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purch…
Boston Scientific registers year-over-year improvement in sales, indicating solid market share gains in legacy businesses despite macroeconomic odds.
Roth Mkm reiterated a “buy” rating and set a $389.00 price objective on shares of Boston Beer in a research note on Wednesday.
Boston Scientific Co. (NYSE:BSX – Get Free Report) saw unusually large options trading on Wednesday. Stock investors acquired 12,824 put options on the stock. This is an increase of approximately 41% compared to the average daily volume of 9,068 put op…
Boston Scientific stock pulled back from its run at a record high on Wednesday despite reporting a sweeping third-quarter beat.
The post Boston Scientific's Rockstar Segment Just Fumbled — And So Did Its Shares appeared first on Investor's Bu…
Foresight Group Ltd Liability Partnership lowered its position in Boston Properties, Inc. (NYSE:BXP – Free Report) by 23.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2…
Boston Scientific (BSX) delivered earnings and revenue surprises of 8.62% and 4.35%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Boston Scientific (NYSE:BSX) updated its FY 2024 earnings guidance. The company provided EPS guidance of 2.450-2.470 for the period, compared to the consensus estimate of 2.410. The company also issued revenue guidance of $16.6 billionillion-$16.6 b…
Piper Sandler upgraded shares of Boston Properties from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $78.00 to $105.00 in a research report on Wednesday.
The parents of a high school senior in Massachusetts argued in federal court in Boston that their son was unfairly punished for using artificial intelligence while researching a history project, harming his prospects for acceptance to an elite college
Bank of America lifted their target price on Boston Scientific from $90.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday.
Whittier Trust Co. grew its stake in Boston Properties, Inc. (NYSE:BXP – Free Report) by 4.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 296,354 shares …
Boston Scientific Co. (NYSE:BSX – Get Free Report) was the recipient of unusually large options trading activity on Monday. Stock investors bought 17,842 call options on the stock. This is an increase of 116% compared to the average volume of 8,263 ca…
BSX receives FDA approval for the FARAWAVE NAV Ablation Catheter and FARAVIEW Software, enhancing cardiac mapping and ablation workflows for AF treatment.
Canaccord Genuity Group upped their target price on Boston Scientific from $88.00 to $98.00 and gave the stock a “buy” rating in a research report on Monday.
Raymond James & Associates raised its stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 15.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund own…
Cyndeo Wealth Partners LLC lessened its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 21.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor…
Shares of The Boston Beer Company, Inc. (NYSE:SAM – Get Free Report) have been given an average recommendation of “Hold” by the twelve ratings firms that are covering the company, Marketbeat reports. One equities research analyst has rated the stock …
Boston Pizza Royalties Income Fund (TSE:BPF.UN) declared a monthly dividend on Monday, October 21st. Shareholders of record on Thursday, October 31st will be given a dividend of 0.113 per share on Thursday, October 31st. This represents a $1.36 annuali…
The Stock Market News is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live qoute and chart technical analysis, opinion, price forecast on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.
Stock Market News